Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-fv566 Total loading time: 0 Render date: 2024-07-18T06:35:16.580Z Has data issue: false hasContentIssue false

52 - Pharmacotherapy of Dystonia

An Overview

from Section VII - Pharmacotherapy for Dystonia

Published online by Cambridge University Press:  31 May 2018

By
Vladimir S. Kostić  and
Zvezdan Pirtošek
Edited by
Dirk Dressler ,
Eckart Altenmüller  and
Joachim K. Krauss
Dirk Dressler
Affiliation:
Hannover Medical School
Eckart Altenmüller
Affiliation:
Hochschule für Musik, Theater und Medien, Hannover
Joachim K. Krauss
Affiliation:
Hannover Medical School
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Treatment of Dystonia , pp. 263 - 267
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Albanese, A, Asmus, F, Bhatia, KP, Elia, AE, Elibol, B, Filippini, G, Gasser, T, Krauss, JK, Nardocci, N, Newton, A, Valls-Solé, J (2011) EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 18: 5–18.CrossRefGoogle ScholarPubMed
Balash, Y, Giladi, N (2004) Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options. Eur J Neurol 11: 361–370.Google Scholar
Burke, RE, Fahn, S, Marsden, C (1986) Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology 36: 160–164.CrossRefGoogle ScholarPubMed
Chen, JJ, Ondo, WG, Dashtipour, K, Swope, DM (2012) Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin Therapeutics 7: 1487–1504.CrossRefGoogle Scholar
Cloud, LJ, Jinnah, HA (2010) Treatment strategies for dystonia. Expert Opin Pharmacotherap 11: 5–15.CrossRefGoogle ScholarPubMed
Consroe, P, Sandyk, R, Snider, SR (1986) Open label evaluation of cannabidiol in dystonic movement disorders. Int J Neurosci 30: 277–282.CrossRefGoogle ScholarPubMed
Delnooz, CCS, van de Warrenburg, BPC (2012) Current and future medical treatment in primary dystonia. Ther Adv Neurol Disord 5: 221–240.CrossRefGoogle ScholarPubMed
Dressler, D, Altenmueller, E, Bhidayasiri, R, Boholega, S, Chana, P, Chung, TM, Frucht, S, Garcia-Ruiz, PJ, Kaelin, A, Kaji, R, Kanovsky, P, Laskawi, R, Micheli, F, Orlova, O, Relja, M, Rosales, R, Slawek, J, Timerbaeva, S, Warner, TT, Adib Saberi, F (2015a) Strategies for treatment of dystonia. J Neural Transm 123: 251–258.CrossRefGoogle ScholarPubMed
Dressler, D, Berweck, S, Chatzikalfas, A, Ebke, M, Frank, B, Hesse, S, Huber, M, Krauss, JK, Mücke, K-H, Nolte, A, Oelmann, H-D, Schönle, PW, Schmutzler, M, Pickenbrock, H, Van der Ven, C, Veelken, N, Vogel, M, Vogt, T, Adib Saberi, F (2015b) Intrathecal baclofen therapy in Germany: proceedings of the IAB-Interdisciplinary Working Group for Movement Disorders consensus meeting. J Neural Transm 122:1573–1579.CrossRefGoogle Scholar
Fox, SH, Kellett, M, Moore, AP, Crossman, AR, Brotchie, JM (2002) Randomised, double blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia. Mov Disord 17:145–149.CrossRefGoogle ScholarPubMed
Grassi, E, Latorraca, S, Piacentini, S, Marini, P, Sorbi, S (2000) Risperidone in idiopathic and symptomatic dystonia: preliminary experience. Neurol Sci 21:121–123.CrossRefGoogle ScholarPubMed
Greene, P (1992) Baclofen in the treatment of dystonia. Clin Neuropharmacol 15: 276–288.CrossRefGoogle ScholarPubMed
Greene, P, Shale, H, Fahn, S (1988) Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs. Mov Disord 3: 46–60.CrossRefGoogle ScholarPubMed
Isgreen, WP (1976) Carbamazepine in torsion dystonia. Adv Neurol 14: 411–416.Google Scholar
Jankovic, J (2006) Treatment of dystonia. Lancet Neurol 5: 864–872.Google Scholar
Jankovic, J (2009) Treatment of hyperkinetic movement disorders. Lancet Neurol 8: 844–855.CrossRefGoogle ScholarPubMed
Jankovic, J (2013) Medical treatment of dystonia. Mov Disord 28: 1001–1012.CrossRefGoogle ScholarPubMed
Kluger, B, Triolo, P, Jones, W, Jankovic, J (2015) The therapeutic potential of cannabinoids for movement disorders. Mov Disord 30: 313–327.CrossRefGoogle ScholarPubMed
Koppel, BS, Brust, JC, Fife, T, Bronstein, J, Youssof, S, Gronseth, G, Gloss, D (2014) Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders. Neurology 82: 1556–1563.CrossRefGoogle ScholarPubMed
Lang, AE (1988) Dopamine agonists and antagonists in treatment of idiopathic dystonia. Adv Neurol 50: 561–570.Google ScholarPubMed
Lin, JJ, Chang, DC (2004) Improvement of generalized dystonia by olanzapine treatment. J Clin Neurosci 11: 84–86.CrossRefGoogle ScholarPubMed
Lucetti, C, Nuti, A, Gambaccini, G, Bernardini, S, Brotini, S, Manca, ML, Bonuccelli, U (2000) Mexiletine in the treatment of torticollis and generalized dystonia. Clin Neuropharmacol 23: 186–189.CrossRefGoogle ScholarPubMed
Marsden, CD, Marion, MH, Quinn, N (1984) The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatry 47: 1166–1173.CrossRefGoogle ScholarPubMed
Nutt, JG, Hammerstad, JP, Carter, JH, deGarmo, PL (1985) Lisuride treatment of focal dystonias. Neurology 35: 1242–1243.CrossRefGoogle ScholarPubMed
Thiel, A, Dressler, D, Kistel, C, Rüther, E (1994) Clozapine treatment of spasmodic torticollis. Neurology 44: 957–958.CrossRefGoogle ScholarPubMed
van der Plus, AA, Schilder, JC, Marinus, J, van Hilten, JJ (2013) An explanatory study evaluating the muscle relaxant effects of intramuscular magnesium sulphate for dystonia in complex regional pain syndrome. J Pain 14: 1341–1348.Google Scholar
Zuddas, A, Cianchetti, C (1996) Efficacy of risperidone in idiopathic segmental dystonia. Lancet 347: 127–128.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×